Rebif
REBIF: (interferon Beta 1-a)
Sorono, Inc.
Rebif was FDA approved in March 2002. It is taken 3 times a week, subcutaneous ( under the skin ) injection. It has flu-like symptoms following injection which lessen over time for many. Less common: abnormalities of liver function and decreases in red or white blood cell counts.
Comprehensive Support and if you need help you can contact MS Life at www.MSLifeLines.com or call 1-877-477-3243
Annual costs vary. Please check with your pharmacy
www.drugstore.com05-16-10